These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 24561654)

  • 21. [Epigenetic mechanism of cardiac differentiation of stem cells].
    Zhu H; Liu Y; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1217-21. PubMed ID: 22246356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-dependent clinical prognostic value of histone modifications in colorectal cancer.
    Goossens-Beumer IJ; Benard A; van Hoesel AQ; Zeestraten EC; Putter H; Böhringer S; Liefers GJ; Morreau H; van de Velde CJ; Kuppen PJ
    Transl Res; 2015 May; 165(5):578-88. PubMed ID: 25488396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetics of colorectal cancer: biomarker and therapeutic potential.
    Jung G; Hernández-Illán E; Moreira L; Balaguer F; Goel A
    Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):111-130. PubMed ID: 31900466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics in lung cancer diagnosis and therapy.
    Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
    Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy.
    Shinde S; Saxena S; Dixit V; Tiwari AK; Vishvakarma NK; Shukla D
    Crit Rev Oncog; 2020; 25(2):95-109. PubMed ID: 33389860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic biomarkers in colorectal cancer diagnostics.
    Rawson JB; Bapat B
    Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Modifications in Head and Neck Cancer.
    Gaździcka J; Gołąbek K; Strzelczyk JK; Ostrowska Z
    Biochem Genet; 2020 Apr; 58(2):213-244. PubMed ID: 31712935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.
    Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E
    Drug Resist Updat; 2011 Dec; 14(6):280-96. PubMed ID: 21955833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic-based therapy for colorectal cancer: Prospect and involved mechanisms.
    Rezapour S; Hosseinzadeh E; Marofi F; Hassanzadeh A
    J Cell Physiol; 2019 Nov; 234(11):19366-19383. PubMed ID: 31020647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response.
    Herrera-Solorio AM; Armas-López L; Arrieta O; Zúñiga J; Piña-Sánchez P; Ávila-Moreno F
    Clin Epigenetics; 2017; 9():98. PubMed ID: 28904641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting aberrant chromatin structure in colorectal carcinomas.
    Konishi K; Issa JP
    Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic mechanisms in gastric cancer.
    Gigek CO; Chen ES; Calcagno DQ; Wisnieski F; Burbano RR; Smith MA
    Epigenomics; 2012 Jun; 4(3):279-94. PubMed ID: 22690664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epigenetic research progress in colorectal cancer].
    Qin L; Kang A
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):830-836. PubMed ID: 31413224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.
    Bartosch C; Lopes JM; Jerónimo C
    Epigenomics; 2017 Jun; 9(6):873-892. PubMed ID: 28523964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.
    Ajithkumar P; Vasantharajan SS; Pattison S; McCall JL; Rodger EJ; Chatterjee A
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic modifications in gastric cancer: Focus on DNA methylation.
    Ebrahimi V; Soleimanian A; Ebrahimi T; Azargun R; Yazdani P; Eyvazi S; Tarhriz V
    Gene; 2020 Jun; 742():144577. PubMed ID: 32171825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
    Postwala H; Shah Y; Parekh PS; Chorawala MR
    Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic reprogramming in breast cancer: from new targets to new therapies.
    Katz TA; Huang Y; Davidson NE; Jankowitz RC
    Ann Med; 2014 Sep; 46(6):397-408. PubMed ID: 25058177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of gut microbiota in epigenetic regulation of colorectal Cancer.
    Zhao Y; Wang C; Goel A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188490. PubMed ID: 33321173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.